Pet cancer cases and patterns of treatment at a Spanish veterinary teaching hospital: a retrospective study from 2015 to 2024
- PMID: 40697645
- PMCID: PMC12279513
- DOI: 10.3389/fvets.2025.1588840
Pet cancer cases and patterns of treatment at a Spanish veterinary teaching hospital: a retrospective study from 2015 to 2024
Abstract
Cancer is one of the most common causes of death for companion animals. The study aimed to describe the characteristics of the clinical cases of pets attending at the Veterinary Teaching Hospital (University of Leon, Spain) and diagnosed with tumors. A retrospective study was carried out between 2015 and 2024. A total of 123 animals comprising 107 dogs and 16 cats were obtained from the clinical records. A mean annual incidence risk of 530 of 100,000 animals was calculated. Most animals were dogs (87.0%), females (62.6%), purebred (77.2%) and aged (78.9%). Tumors were mainly malignant (87.8%), they were of epithelial origin (40.7%), and mostly located in mammary glands (27.6%) or skin/mucosa (26.8%). Carcinoma (35.8%) and lymphoma (19.5%) were the major histological types. Almost half of the animals underwent surgical treatment (42.3%). Chemotherapy was administered to 37.4% of the animals, mostly by the oral route. QL01E (protein kinase inhibitors) was the main pharmacological group employed. Concomitant treatments and dietary supplements were also used. Euthanasia was applied to 26.8% of the animals.
Keywords: antineoplastic agent; cancer; chemotherapy; pet; prescription; surgery; veterinary teaching hospital.
Copyright © 2025 Romero, Susperregui, Díez, Vazquez, Lopez, de la Puente, Diez, Fernandez, Rodriguez-Altonaga and Sahagun.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Apr 19;4:CD011535. doi: 10.1002/14651858.CD011535.pub4. PMID: 31917873 Free PMC article. Updated.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
References
-
- Withthrow S. “Introduction: why worry about Cancer in pets?” In Withrow & MacEwen’s Small Animal Clinical Oncology. 4th ed, editors S. Withrow, DM. Vail. (St. Louis, MO: WB Saunders; ) (2007) xv–xvii. doi: 10.1016/B978-072160558-6.50003-4, PMID: - DOI
LinkOut - more resources
Full Text Sources
Miscellaneous